Portuguese doctors decry poor biomedical R&D vision
This article was originally published in Clinica
Portugal must do more to incentivise biomedical R&D and to cultivate a closer relationship between the research and clinical sectors. So argues Joao Lobo Antunes, president of the national academy of medicine (APM). In an interview with Diario Economico (January 30), he noted, however, that important research into biomedical and IT-related medical technologies is underway: he highlighted the fields of neuroscience, genetics and the role of the various research facilities attached to the ministry for science and technology.
You may also be interested in...
Listerine mouthwash drove J&J’s oral care sales up 11.4% in the fourth quarter. Tylenol for adults was the star of its OTC drug business but weakness of children’s Tylenol products and other OTCs led to flat sales.
Nutritional Brands rolls out NB Pure as brand, including logo, packaging design and website, for all its supplements after 25 years. “When you looked at our label for one brand and looked at the label for another brand, there was no symmetry between the two,” says CEO Danna Pratt.
Sanofi will fill and package 100 million doses of a rival vaccine for the European market in 2021 in a sign of how the industry is working to meet an unprecedented demand for COVID-19 vaccines.